Skip to content

Influence of a 4-week combined strength and endurance training in post-covoid patients with chronic performance reduction and fatique symptoms - pilot study

Influence of a 4-week combined strength and endurance training in post-covoid patients with chronic performance reduction and fatique symptoms - pilot study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00026686
Enrollment
80
Registered
2021-09-27
Start date
2021-09-27
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

U07.1 U09.9

Interventions

Group 1: Strength and endurance training (2-3x per week for 4 weeks) Group 2: Observation

Sponsors

Klinik und Poliklinik für Kardiologie am Universitätsklinikum Leipzig
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Patients with persistent fatigue after cured COVID-19 disease min. 6 weeks, MFI > 50 min 4/5 areas affected - Post-Covid Functional Scale ± 2 - Normal LVEF - Nt-pro-BNP, troponin T in normal range - FEV1 and FVC within normal range

Exclusion criteria

Exclusion criteria: - Known underlying pulmonary or cardiac disease defined as heart failure with preserved or reduced pump function, myocarditis, known coronary artery disease, obstructive restrictive lung disease. - COVID-19 conditional cardiovascular complication e.g. pulmonary embolism, pulmonary fibrosis, myocardial infarction, myocarditis. - Lack of consent - Pregnancy - Age<18 years

Design outcomes

Primary

MeasureTime frame
- Subjective improvement in perceived fatigue according to MFI-20 in at least 2 of 5 categories at follow-up (1st/3rd/6th month)

Secondary

MeasureTime frame
- VO2 max., O2 pulse - Improvement in quality of life according to McGill Quality of Life Questionnaire (MQOL) - Improvement in Post-Covid-Functional-Scale - 1-RM (Repetition maximum) - Strength performance - Leisure time activity (Physical activity Assessment) - Cardiac enzymes, CBC, NLRP3 inflammasome, inflammatory parameters 1st month follow-up, questionnaires also 3rd month and 6th month

Countries

Germany

Contacts

Public ContactSven Fikenzer

Universitätsklinikum Leipzig

sven.fikenzer@medizin.uni-leipzig.de03419712650

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 8, 2026